CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
86 hedge funds and large institutions have $1.74B invested in China Biologic Products Holdings, Inc. in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 27 increasing their positions, 34 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
86
Holders Change
-3
Holders Change %
-3.37%
% of All Funds
1.51%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.09%
New
11
Increased
27
Reduced
34
Closed
14
Calls
$12.8M
Puts
$450K
Net Calls
+$12.3M
Net Calls Change
+$3.85M
Top Buyers
| 1 |
AC
Athos Capital
Hong Kong
|
+$67.2M |
| 2 |
OMC
Oasis Management Company
Grand Cayman,
Cayman Islands
|
+$64.9M |
| 3 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$49.4M |
| 4 |
DKCM
Davidson Kempner Capital Management
New York
|
+$29.8M |
| 5 |
Millennium Management
New York
|
+$27.1M |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$74M |
| 2 |
Capstone Investment Advisors
New York
|
-$50.2M |
| 3 |
YCMGA
York Capital Management Global Advisors
New York
|
-$35.7M |
| 4 |
PAM
PSquared Asset Management
Zurich,
Switzerland
|
-$24.2M |
| 5 |
Two Sigma Investments
New York
|
-$22.2M |
